Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor
article
OA: closed
CC0
⤵ 63 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Two premenopausal women with severe endometriosis were successfully treated using an aromatase inhibitor.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (35)
- Angiogenesis and Macrophage Activation in Endometriosis via openalex
- Angiogenic Factors in Endometriosis via openalex
- Deficient 17β-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17β-Estradiol<sup>1</sup> via openalex
- Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro via openalex
- Endometriosis: Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids via openalex
- Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. via openalex
- Mechanisms of excessive estrogen formation in endometriosis via openalex
- Progesterone and transforming growth factor-β coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis via openalex
- Progesterone Induction of 17β-Hydroxysteroid Dehydrogenase Type 2 during the Secretory Phase Occurs in the Endometrium of Estrogen-Dependent Benign Diseases But Not in Normal Endometrium via openalex
- Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis via openalex
- Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells via openalex
- Prostaglandin E<sub>2</sub>Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells<sup>1</sup> via openalex
- Stimulation of Aromatase P450 Promoter (II) Activity in Endometriosis and Its Inhibition in Endometrium Are Regulated by Competitive Binding of Steroidogenic Factor-1 and Chicken Ovalbumin Upstream Promoter Transcription Factor to the Same cis-Acting Element via openalex
- Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor via openalex
- Vascular endothelial growth factor and endometriotic angiogenesis via openalex
- Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. via openalex
- W6719101208 via openalex
- W6814680148 via openalex
- W1809749161 via openalex
- W6818386271 via openalex
- W1885898936 via openalex
- W1970676517 via openalex
- W2019521296 via openalex
- W2022503451 via openalex
- W2023963334 via openalex
- W2029278810 via openalex
- W2107088721 via openalex
- W2142257913 via openalex
- W2152032472 via openalex
- W2155430176 via openalex
- W2156971618 via openalex
- W2464131775 via openalex
- W4236635561 via openalex
- W4285719527 via openalex
- W6658221620 via openalex
Cited by (50)
- A Systematic Review of Systematic Reviews on the Use of Aromatase Inhibitors for the Treatment of Endometriosis: The Evidence to Date 2023
- Gynecology Relevant to Andrology 2023
- Effectiveness of Norethisterone Acetate alone Versus in Combination with Letrozole for treatment of Chronic Pelvic Chronic Pain and Dyspareunia in Patients with Endometriosis 2022
- Uso de inhibidores de la aromatasa en el tratamiento del dolor pélvico asociado a endometriosis: revisión sistemática 2021
- Evaluation of the effect of aromatase inhibitor in reducing the size of endometrioma 2021
- Letrozole combined with oral contraceptives versus oral contraceptives alone in the treatment of endometriosis-related pain symptoms: a pilot study 2020
- Preparation and <i>in vitro/in vivo</i> evaluation of anastrozole reservoir‐type intravaginal ring 2018
- Drug therapy in the treatment of endometriosis 2016
- Model‐Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis Symptoms 2016
- Emerging treatment of endometriosis 2015
- Experimental Treatments of Endometriosis 2015
- Human Chorionic Gonadotropin Improves Endometriosis Through Downregulation of Leptin Expression in Rats 2015
- Effect of Letrozole on endometriosis-related pelvic pain. 2014
- Role of Aromatase Inhibitors in the Treatment of Endometriosis 2014
- Aromatase Expression in Endometriosis and Its Significance 2014
- Potential role of aromatase inhibitors in the treatment of endometriosis 2014
- Efficacy of letrozole in treatment of endometriosis-related pain 2013
- Aromatase inhibitors for the treatment of endometriosis 2012
- Medical Treatment in Endometriosis 2012
- The role of prostaglandin E <sub>2</sub> in endometriosis 2011
- The use of aromatase inhibitors in infertility and gynecology 2011
- The emerging use of aromatase inhibitors for endometriosis treatment 2011
- Are aromatase inhibitors effective in endometriosis treatment? 2011
- Potential cures for endometriosis 2011
- Endometriosis: Current and Emerging Therapies 2011
- Medical Therapies: Aromatase Inhibitors 2011
- Traitement de l’endométriose par les inhibiteurs de l’aromatase : efficacité thérapeutique et conséquences osseuses 2010
- Management of Endometriosis-associated Pain 2010
- Current pharmacotherapy for endometriosis 2010
- Use of aromatase inhibitors in gynecology 2010
- Endometriosis 2009
- Pharmacological Treatment of Endometriosis 2009
- Estrogen metabolism and action in endometriosis 2009
- Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients 2009
- Medical treatment of endometriosis. 2009
- Aromatase inhibitors in the treatment of deep endometriosis 2009
- Aromatase Inhibitors: Potential Reproductive Implications 2009
- Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor 2008
- Endometriosis and Chronic Pelvic Pain: Unraveling the Mystery Behind this Complex Condition 2008
- Treatment strategies for endometriosis 2008
- Emerging drugs for endometriosis 2008
- New drugs in development for the treatment of endometriosis 2008
- Endometriosis 2008
- Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis 2008
- Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue 2007
- Selective Estrogen-Receptor Modulators and Aromatase Inhibitors: Promising New Medical Therapies for Endometriosis? 2007
- Metformin Suppresses Interleukin (IL)-1β-Induced IL-8 Production, Aromatase Activation, and Proliferation of Endometriotic Stromal Cells 2007
- Alternative Therapieoptionen bei Endometriose 2007
- Expression und Regulation von Enzymen des Östrogenmetabolismus in humanen Endometriumläsionen kultiviert in der Nacktmaus 2007
- Letrozole and desogestrel‐only contraceptive pill for the treatment of stage IV endometriosis 2007
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:12:32.173627+00:00
License: CC0
· commercial use OK